XML 20 R7.htm IDEA: XBRL DOCUMENT v3.24.1
Statements of Changes in Stockholders’ Deficit - USD ($)
Class A
Common Stock
Class B
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2021 $ 89 $ 876 $ (5,979,383) $ (5,978,418)
Balance (in Shares) at Dec. 31, 2021 890,000 8,763,333      
Forfeiture of Founder Shares $ (15) 15
Forfeiture of Founder Shares (in Shares) (148,192)      
Sale of private placement units in over-allotment $ 9 860,801 860,810
Sale of private placement units in over-allotment (in Shares) 86,081      
Sale of Public Units in over-allotment, net of offering costs 454,360 454,360
Accretion of common stock subject to possible redemption (1,315,176) (3,638,157) (4,953,333)
Net income (loss) 1,115,764 1,115,764
Balance at Dec. 31, 2022 $ 98 $ 861 (8,501,776) (8,500,817)
Balance (in Shares) at Dec. 31, 2022 976,081 8,615,141      
Excise tax on stock redemption (967,916) (967,916)
Conversion of Class B common stock to Class A common stock $ 861 $ (861)
Conversion of Class B common stock to Class A common stock (in Shares) 8,615,141 (8,615,141)      
Contribution for non-redemption agreements   708,400 708,400
Accretion of common stock subject to possible redemption (1,720,054) (6,979,217) (8,699,271)
Waiver of Deferred Underwriter’s Fee 8,704,270 8,704,270
Net income (loss) 4,443,634 4,443,634
Balance at Dec. 31, 2023 $ 959 $ 6,984,216 $ (11,296,875) $ (4,311,700)
Balance (in Shares) at Dec. 31, 2023 9,591,222